Indivior Pharmaceuticals (INDV) EV to FCF (2024 - 2026)

Indivior Pharmaceuticals has reported EV to FCF for 3 years, with the latest figure at 20.81 in Q2 2026.

• On a quarterly basis, EV to FCF rose 120.78% year-over-year to 20.81 in Q2 2026; TTM through Jun 2026 was 41.62, a 641.77% decrease from a year earlier, with the FY2025 full-year figure at 46.15, down 126.28% from the prior year.
• EV to FCF was 20.81 for Q2 2026 at Indivior Pharmaceuticals, up from 122.11 in the prior quarter.
• The five-year high for EV to FCF was 25.91 in Q2 2024, with the low at 257.4 in Q3 2024.
• Average EV to FCF over 3 years is 48.47, with a median of 27.39 recorded in 2024.
• The largest YoY upside for EV to FCF was 120.78% in 2026 against a maximum downside of 1147.44% in 2026.
• Over 3 years, EV to FCF stood at 37.26 in 2024, then jumped by 52.98% to 17.52 in 2025, then surged by 218.79% to 20.81 in 2026.
• The last three EV to FCF figures came in at 20.81 (Q2 2026), 122.11 (Q1 2026), and 17.52 (Q4 2025), per Business Quant data.